Maresyl (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride is a selective alpha‑adrenergic agonist. When applied to the nasal mucosa, it binds to alpha‑1 receptors on the smooth muscle of blood vessels, causing vasoconstriction. This reduces blood flow, diminishes edema, and opens the nasal passages.

The appropriate dose of Maresyl is determined by a qualified healthcare professional based on the patient’s age, condition, and response. Typically, one or two sprays per nostril are used, but the exact regimen should follow the prescriber’s instructions and the product label.

Safety data for Xylometazoline Hydrochloride in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks with their healthcare provider before using Maresyl.

To place an order, submit an enquiry on the Maresyl product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Maresyl’s active ingredient, Xylometazoline, is an alpha‑adrenergic agonist similar to phenylephrine or oxymetazoline. Compared with phenylephrine, Xylometazoline generally provides a longer duration of action with fewer systemic effects, while oxymetazoline has a comparable efficacy but may have a slightly higher risk of rebound congestion if overused.

Maresyl should be stored at room temperature, preferably below 25 °C. Keep the bottle tightly closed, protect it from moisture, direct sunlight, and excessive heat. Do not freeze the product, and retain it in its original packaging until use.

Maresyl is administered intranasally as a spray. The user tilts the head slightly forward, inserts the nozzle into one nostril, and delivers the prescribed number of sprays while breathing in gently. The same procedure is repeated for the other nostril if required.

Serious risks, though rare, include hypertension, tachycardia, severe nasal ulceration, and allergic reactions such as rash or anaphylaxis. Prolonged use beyond three days can also cause rebound congestion, where nasal blockage worsens after the medication is stopped.

Maresyl should not be used by children under six years of age, individuals taking monoamine oxidase inhibitors, patients with severe hypertension, or anyone who has experienced an allergic reaction to Xylometazoline or any component of the formulation. Consultation with a healthcare professional is essential before use.